By bno - Jakarta bureau For 64 years, USAID has played a role in Indonesia. According to its official website, the agency was ...

DMAb levels remained stable for 72 weeks in all participants (n=24) who have reached that timepointNo anti-drug antibodies (ADA): no immune rejection of the DMAbs was detected across ~1,000 blood ...

Learn more about whether Kymera Therapeutics, Inc. or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ ...

Our new build program is also expected to be substantially completed in 2025. We believe the Company’s current share price does not reflect the strength of our business and that a share repurchase ...

Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

Find out more about why artificial intelligence is having a huge impact on the world of healthcare. Enter now and don't miss ...

Learn more about whether ACADIA Pharmaceuticals Inc. or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ ...

HURON TOWNSHIP — For the last 100 years, at least one member of Jennifer Wells’ family has worked for DTE Energy. Now, she's ...

A new landmark in adaptive reuse and sustainable development... The Elephant, a landmark building undergoing a transformative £132m redevelopment ...

World Glaucoma Week (March 9-15) is ‘Uniting for a Glaucoma-Free World’ with eyecare innovation high on the list of priorities amid an estimated 150,000 people in Scotland living with the condition.

Hanna Gräs, 24, has always had a passion for medicine and research. How she would get there, however, was not as clear. From ...

Innovation, resilience, and vision define the entrepreneurs shaping the business world today. These trailblazers are not only ...